This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

What You're Missing on RealMoney

When you need real-time analysis of what's moving stocks in your portfolio, RealMoney should be your go-to site.

Here's a small sampling of what you missed on RealMoney today and what you're likely to miss over the weekend, if you're not a subscriber:

While the media was abuzz today over Berkshire Hathaway's (BRK-A) annual meeting, which will be held tomorrow in Omaha, Neb., RealMoney's experts were getting ready for real-time coverage. Two of our experts are traveling to Omaha to cover Berkshire Hathaway's annual meeting on Saturday and will post real-time analysis on RealMoney throughout the day.

RealMoney also offered analysis on Berkshire today, as Doug Kass provided these comments in Columnist Conversation:

"Great interview in Omaha between Becky Quick and my buddy/friend/pal, Mario Gabelli.

"Straight-talking from one of the best stock pickers extant.

"Speaking of Omaha, the Woodstock of Capitalism starts tomorrow morning.

"I discussed Berkshire Hathaway in this morning's Financial Times.

"At $93,000, Berkshire is trading at a marked discount to its intrinsic value of near $120,000.

"It is among my largest long positions."

Many of our readers on TheStreet.com were following Sepracor (SEPR) after it was downgraded. Subscribers to RealMoney were not short on analysis from our experts. Vince Farrell posted this entry to his trading diary:

" Sepracor is the object of a ratings downgrade by Goldman Sachs (GS - Get Report) today. Manoj Garg of Soliel/Health Research would disagree. The stock trades for about one times revenue and has a solid base of products and an interesting pipeline.

"Consensus for 2009 is $2.43 and $2.75 for 2010. Garg has higher numbers: His 2009 is $2.72 and $3.12 for next year. The stock at $13 now trades at only 5 times the consensus number for this year and the company also has almost $6 in cash per share and net operating loss carryforwards.

"Garg would be a buyer with a $24 target."

RealMoney's experts also provided some shrewd commentary on Sepracor, with comparisons to other stocks that investors should consider. David Sterman, a RealMoney contributor, weighed in early with "The Hunt for Low PEs," which provided insightful analysis on four stocks.

One of the most popular stories on TheStreet.com on Friday was our coverage of railroad stocks. Subscribers on RealMoney received more than the latest headlines; they received analysis on much of the railroad sector from contributor Jeff Miller:

"Investors who share my respect for our colleague Anirvan Banerji and the Economic Cycle Research Institute (ECRI) should do two things:

"1) Read his excellent article describing the ECRI methods, results and current findings, and

"2) Consider adding some economically sensitive stocks to your portfolio.

"Railroads are one idea. Norfolk Southern (NSC - Get Report) is lower on a downgrade to neutral reportedly because an analyst does not like the exposure to coal traffic. In an improving economy, Norfolk Southern will do very well, as will Burlington Northern Santa Fe (BNI) and CSX (CSX - Get Report).

"I also expect the rails to get some positive mention this weekend in Omaha."

You can't afford to ignore the experts on RealMoney. Click here for a free trial. RealMoney: The profits are waiting for you.

Dave Morrow

Editor-in-Chief

David Morrow is editor-in-chief of TheStreet.com. In keeping with TSC's editorial policy, he doesn't own or short individual stocks, though he owns stock in TheStreet.com. He also doesn't invest in hedge funds or other private investment partnerships. He appreciates your feedback; click here to send him an email.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
CSX $32.88 0.70%
GS $209.31 0.25%
NSC $87.81 0.52%
AAPL $126.34 0.73%
FB $86.66 1.00%

Markets

DOW 17,721.63 +102.12 0.58%
S&P 500 2,070.40 +7.29 0.35%
NASDAQ 4,995.2350 +8.3680 0.17%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs